Cargando…

Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments

Although the discovery and characterization of multiple tumor antigens have sparked the development of many antigen/derived cancer vaccines, many are poorly immunogenic and thus, lack clinical efficacy. Adjuvants are therefore incorporated into vaccine formulations to trigger strong and long-lasting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuzzubbo, Stefania, Mangsbo, Sara, Nagarajan, Divya, Habra, Kinana, Pockley, Alan Graham, McArdle, Stephanie E. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927599/ https://www.ncbi.nlm.nih.gov/pubmed/33679703 http://dx.doi.org/10.3389/fimmu.2020.615240

Ejemplares similares

Editorial: Frontiers’ Research Topic “Cancer Vaccines: Time to Think Differently!”
por: McArdle, Stephanie E. B., et al.
Publicado: (2021)

Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
por: Pearson, Joshua R. D., et al.
Publicado: (2020)

Robust formation of optimal single spheroids towards cost‐effective in vitro three‐dimensional tumor models
por: Habra, Kinana, et al.
Publicado: (2023)

Prostate cancer: Important steps and considerations in the design of therapeutic vaccines
por: McArdle, Stephanie EB, et al.
Publicado: (2014)

Synthesis and Functionalisation of Superparamagnetic Nano-Rods towards the Treatment of Glioblastoma Brain Tumours
por: Habra, Kinana, et al.
Publicado: (2021)

Controlled release of carnosine from poly(lactic-co-glycolic acid) beads using nanomechanical magnetic trigger towards the treatment of glioblastoma
por: Habra, Kinana, et al.
Publicado: (2022)

Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation
por: Hood, Simon P., et al.
Publicado: (2019)

Identifying the Presence of Prostate Cancer in Individuals with PSA Levels <20 ng ml(−1) Using Computational Data Extraction Analysis of High Dimensional Peripheral Blood Flow Cytometric Phenotyping Data
por: Cosma, Georgina, et al.
Publicado: (2017)

A Novel HAGE/WT1-ImmunoBody(®) Vaccine Combination Enhances Anti-Tumour Responses When Compared to Either Vaccine Alone
por: Almshayakhchi, Rukaia, et al.
Publicado: (2021)

Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast Cancer
por: Foulds, Gemma A., et al.
Publicado: (2018)

Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
por: Flingai, Seleeke, et al.
Publicado: (2013)

Prostate Cancer: Early Detection and Assessing Clinical Risk Using Deep Machine Learning of High Dimensional Peripheral Blood Flow Cytometric Phenotyping Data
por: Cosma, Georgina, et al.
Publicado: (2021)

Immune Landscape of Breast Cancers
por: Nagarajan, Divya, et al.
Publicado: (2018)

Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential
por: Ellingsen, Espen Basmo, et al.
Publicado: (2021)

Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer
por: Shackleton, Erin G., et al.
Publicado: (2021)

A Mutated Prostatic Acid Phosphatase (PAP) Peptide-Based Vaccine Induces PAP-Specific CD8(+) T Cells with Ex Vivo Cytotoxic Capacities in HHDII/DR1 Transgenic Mice
por: Vu, Pauline Le, et al.
Publicado: (2022)

SRA inhibition improves antitumor potency of antigen-targeted chaperone vaccine
por: Qian, Jie, et al.
Publicado: (2023)

Adjuvants for Coronavirus Vaccines
por: Liang, Zhihui, et al.
Publicado: (2020)

Vaccine Adjuvant Informatics: From Data Integration and Analysis to Rational Vaccine Adjuvant Design
por: He, Yongqun
Publicado: (2014)

Vaccine Adjuvants: Mode of Action
por: De Gregorio, Ennio, et al.
Publicado: (2013)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

Cancer Vaccines, Adjuvants, and Delivery Systems
por: Paston, Samantha J., et al.
Publicado: (2021)

Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings
por: Vázquez-Maldonado, Nancy, et al.
Publicado: (2023)

The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant Formulation
por: George, Parakkal Jovvian, et al.
Publicado: (2020)

Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform
por: Pérez, Oliver, et al.
Publicado: (2013)

An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines
por: Bodle, Jesse, et al.
Publicado: (2023)

Vaccine adjuvants to engage the cross-presentation pathway
por: Lee, Woojong, et al.
Publicado: (2022)

Potentials of saponins-based adjuvants for nasal vaccines
por: Chen, Kai, et al.
Publicado: (2023)

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Crohn’s Disease: Current Status and Future Directions. A Review on Behalf of the EBMT Autoimmune Diseases Working Party and the Autologous Stem Cell Transplantation In Refractory CD—Low Intensity Therapy Evaluation Study Investigators
por: Pockley, Alan Graham, et al.
Publicado: (2018)

Rapid determination of influenza vaccine potency by an SPR-based method using subtype or lineage-specific monoclonal antibodies
por: Narayan, Kartik, et al.
Publicado: (2023)

Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention
por: Nasi, Aikaterini, et al.
Publicado: (2020)

Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data
por: Hood, Simon P, et al.
Publicado: (2020)

Potency assays and biomarkers for cell-based advanced therapy medicinal products
por: Capelli, Chiara, et al.
Publicado: (2023)

Adjuvants for Leishmania vaccines: from models to clinical application
por: Raman, Vanitha S., et al.
Publicado: (2012)

Modulation of Primary Immune Response by Different Vaccine Adjuvants
por: Ciabattini, Annalisa, et al.
Publicado: (2016)

AS03- and MF59-Adjuvanted Influenza Vaccines in Children
por: Wilkins, Amanda L., et al.
Publicado: (2017)

Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant
por: Cheong, Yucheol, et al.
Publicado: (2021)

New-age vaccine adjuvants, their development, and future perspective
por: Verma, Shailendra Kumar, et al.
Publicado: (2023)

Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics
por: Mellors, Jack, et al.
Publicado: (2020)

Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants
por: Sui, Yongjun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5p3fodvja1sjflk63rsvrrpnbh